• People

    Advanced Search

  • Services
  • All Services


  • As of February 3, 2025, Stark & Stark is no longer accepting inquiries for this litigation.


    Singulair is Merck’s brand name for the drug montelukast. Singulair is prescribed to treat asthma, as well as allergic rhinitis (hay fever) and other bronchial disorders. Since its approval in 1998, Singulair has been widely prescribed to millions of patients in the United States for its anti-inflammatory properties. It is available in tablets or granules and is usually used in conjunction with a corticosteroid inhaler.

    Unfortunately, Singulair use has given rise to numerous studies and recent well-publicized lawsuits across the country, contending that Singulair can cause severe mental health side effects with long-term use. Moreover, many of these side effects have been observed in children and young adults – including suicidal thoughts or actions.

    Have you or your children experienced severe mental health side effects? Have you taken Singulair? You may be entitled to compensation. Speak with our Singulair attorneys today, free of charge, to be sure.

    What Does the United States Food and Drug Administration say About Singulair?

    The FDA has pointed to studies demonstrating severe mental health side effects, even after discontinued use of Singulair. These side effects may include:

    • agitation, including aggressive behavior or hostility
    • attention problems
    • bad or vivid dreams
    • depression
    • disorientation or confusion
    • feeling anxious
    • hallucinations (seeing or hearing things that are not really there)
    • irritability
    • memory problems
    • obsessive-compulsive symptoms
    • restlessness
    • sleepwalking
    • stuttering
    • tremor or shakiness
    • trouble sleeping
    • uncontrolled muscle movement

    Most significantly, Prolonged use of Singulair has been found to lead to suicidal thoughts or actions.

    Accordingly, in March 2020, the FDA required a Black Box Warning, the most prominent warning, to be added to the prescribing information of montelukast to describe these serious mental health side effects and to recommend that montelukast should only be reserved to treat allergic rhinitis in patients who are not treated effectively with or cannot tolerate other allergy medicines. The FDA also required a new patient Medication Guide to educate patients and parents/caregivers about the medicine.

    This has spawned lawsuits across the country, contending that the makers of Singulair knew of the severe mental health side effects for years, but failed to properly warn patients. Many of those patients were children or young adults who were the unknowing victims of suicidal thoughts or actions.

    If you or your children have taken Singulair over an extended period of time and suffered severe mental health side effects, you could be eligible to participate in ongoing national Singulair lawsuits and settlements. But your claims may be subject to time limitations. Speak with our Singulair attorneys today, free of charge, so that you can know your rights.

    How Can We Help You With Your Singulair Claim?

    The attorneys of Stark & Stark’s Mass Tort and Class Action Team of lawyers have successfully represented thousands of clients throughout the nation in Defective Drug and Medical Device Mass Actions, Toxic Tort Mass Actions, Employment and Civil Rights Class and Mass Actions, Investor/Securities Class Actions, and Consumer Fraud Class Actions.

    We are not a marketing company. The Stark & Stark law firm is not like many of the marketing companies you have seen on television. Established in 1933, we are a firm of over 100 attorneys in offices throughout New York, New Jersey and Pennsylvania, including experienced trial attorneys that you can meet and talk to about your case and possible Singulair settlement. Stark & Stark is committed to holding drug and medical device manufacturers liable when their products improperly endanger the public. Our Singulair attorneys are experienced in class action, mass tort and multidistrict litigation cases and in negotiating with medical device and pharmaceutical settlement representatives. If you or a member of your family has suffered severe mental health side effects from Singulair use, you may be entitled to compensation via litigation and/or settlement.

    Please contact Stark & Stark to speak with one of the Singulair, who can help assess any claims that you may have and to help you to understand the Singulair lawsuit and settlement process. There is no obligation and no cost to you. We are experienced in Singulair lawsuits and settlements, allow us to help you today.

    Speak with an Experienced Attorney Today

    Firm Highlights

    Stark & Stark Shareholder Deborah S. Dunn, Esq. Installed as 2nd Vice President and Diversity Officer of the New Jersey Association for Justice for 2026–2027

    Stark & Stark is proud to announce that Shareholder Deborah S. Dunn, Esq. has been installed as 2nd Vice President and Diversity Officer of the...

    Stark & Stark Recognized with Community Partner Award by Mercer County Community College Foundation

    Stark & Stark is proud to announce that the firm has been recognized with the Community Partner Award by the Mercer County Community College...

    Carin A. O’Donnell, Esq. Inducted as 2026-2027 President of the Pennsylvania Association for Justice

    Stark & Stark is proud to announce that Carin A. O'Donnell, Esq. was sworn in as the 2026-2027 President of the Pennsylvania Association for...

    Stark & Stark’s Thomas S. Onder, Esq. Receives 2026 ICSC Trustees’ Distinguished Service Award

    Stark & Stark is proud to announce that Thomas S. Onder, Esq., Shareholder and Chair of the Firm’s Shopping Center & Retail Development...

    Stark & Stark’s Joseph H. Lemkin Esq., Named 2026 Professional Lawyer of the Year for the Jewish Bar Association of New Jersey

    Stark & Stark is proud to announce that Joseph H. Lemkin Esq. has been selected by the New Jersey Commission on Professionalism in the Law as...

    Our Values Remain: A Message on the Closing of Diversity Lab

    Stark & Stark is saddened and disappointed to learn that Diversity Lab, the organization that created and manages the Mansfield Certification...

    Congratulations to Shareholder Bhaveen R. Jani, Esq. on his Installation as Treasurer of the Middlesex County Bar Foundation

    Stark & Stark is proud to announce that Shareholder Bhaveen R. Jani, Esq. has been installed as Treasurer of the Middlesex County Bar Foundation,...

    Denise Mariani, Esq., and Jonathan Lauri, Esq. Secure $750,000 Jury Verdict Against Hamilton Healthcare and Rehabilitation Center

    It is our pleasure to announce that Denise Mariani, Esq., and Jonathan Lauri, Esq., secured a $750,000 jury verdict on behalf of a nursing home...

    Stark & Stark Welcomes 2026 Summer Law Clerks

    Stark & Stark is proud to announce its 10th Annual Summer Law Clerk Program. Five Summer Law Clerks will join the firm from June through July...

    Retail Development Team Secures Major Recovery for Landlord Client Amid Bankruptcy Dispute

    Our Shopping Center and Retail Development Group recently secured a multi-million-dollar settlement for a commercial landlord client' s property...

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. Secure $950,000 Settlement in Surgical Malpractice Matter

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. recently secured a confidential $950,000 settlement in a surgical malpractice case. “This...

    Victoria Wilton, Esq. Selected to Serve on New Jersey State Bar Association Family Law Executive Committee

    We are proud to announce that Victoria Wilton, Esq. has been selected to serve on the New Jersey State Bar Association Family Law Executive Committee...